Medical World News® Behind the Science: Experts Discuss Key Research for Pancreatic Cancer Awareness Month

Video

CancerNetwork® spoke with Allyson J. Ocean, MD, Diane M. Simeone, MD, Manuel Hidalgo Medina, MD, PhD, and Andrew E. Hendifar, MD, about their recent research into the treatment of pancreatic cancer.

November is Pancreatic Cancer Awareness month and a good time to reflect on recent advancements in care for patients with these difficult to treat tumors. Since pancreatic tumors rarely produce symptoms in earlier stages, patients typically present with disease that is in advanced stages when it is most difficult to control. Additionally, options for systemic therapies are limited.

In a Behind the Science segment of the Medical World News® broadcast, CancerNetwork® met with Allyson J. Ocean, MD, Diane M. Simeone, MD, Manuel Hidalgo Medina, MD, PhD, and Andrew E. Hendifar, MD, oncologists who specialize in the treatment of pancreatic cancer, to discuss recent research that has the potential to significantly impact care and ongoing trials that clinicians should be aware of.

For a closer look at each of the interviews, see our related articles:

Using Genetic Predispositions to Determine the Likelihood of Being Diagnosed With Pancreatic Cancer

Recent Videos
Only a few groups of patients get screened for pancreatic cancer, those with a genetic risk or pancreatic cysts among them, which can increase lethality for unidentified populations.
The development of RAS-directed vaccines may help decrease the likelihood of disease recurrence in patients undergoing treatment for pancreatic cancer.
Related Content